| Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial S Paramsothy, MA Kamm, NO Kaakoush, AJ Walsh, J van den Bogaerde, ... The Lancet 389 (10075), 1218-1228, 2017 | 1170 | 2017 |
| European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ... Journal of Crohn's and Colitis 3 (2), 47-91, 2009 | 688 | 2009 |
| Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up RV Bryant, DC Burger, J Delo, AJ Walsh, S Thomas, A von Herbay, ... Gut 65 (3), 408-414, 2016 | 382 | 2016 |
| Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis S Paramsothy, S Nielsen, MA Kamm, NP Deshpande, JJ Faith, ... Gastroenterology 156 (5), 1440-1454. e2, 2019 | 378 | 2019 |
| The pattern and outcome of acute severe colitis LC Dinesen, AJ Walsh, MN Protic, G Heap, F Cummings, BF Warren, ... Journal of Crohn's and Colitis 4 (4), 431-437, 2010 | 374 | 2010 |
| Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection M Julsgaard, LA Christensen, PR Gibson, RB Gearry, J Fallingborg, ... Gastroenterology 151 (1), 110-119, 2016 | 348 | 2016 |
| Diagnosis and outcome of small bowel tumors found by capsule endoscopy: a three-center Australian experience AA Bailey, HS Debinski, MN Appleyard, ML Remedios, JE Hooper, ... Official journal of the American College of Gastroenterology| ACG 101 (10 …, 2006 | 254 | 2006 |
| Current best practice for disease activity assessment in IBD AJ Walsh, RV Bryant, SPL Travis Nature reviews Gastroenterology & hepatology 13 (10), 567-579, 2016 | 222 | 2016 |
| HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants GA Heap, MN Weedon, CM Bewshea, A Singh, M Chen, JB Satchwell, ... Nature genetics 46 (10), 1131-1134, 2014 | 210 | 2014 |
| Donor recruitment for fecal microbiota transplantation S Paramsothy, TJ Borody, E Lin, S Finlayson, AJ Walsh, D Samuel, ... Inflammatory bowel diseases 21 (7), 1600-1606, 2015 | 165 | 2015 |
| Comparing disease activity indices in ulcerative colitis AJ Walsh, A Ghosh, AO Brain, O Buchel, D Burger, S Thomas, L White, ... Journal of Crohn's and Colitis 8 (4), 318-325, 2014 | 136 | 2014 |
| Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus L Vuitton, L Peyrin‐Biroulet, JF Colombel, B Pariente, ... Alimentary pharmacology & therapeutics 45 (6), 801-813, 2017 | 126 | 2017 |
| Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional … PR Gibson, C Vaizey, CM Black, R Nicholls, AR Weston, P Bampton, ... Journal of Crohn's and Colitis 8 (7), 598-606, 2014 | 124 | 2014 |
| ECCO position paper: harmonization of the approach to ulcerative colitis histopathology F Magro, G Doherty, L Peyrin-Biroulet, M Svrcek, P Borralho, A Walsh, ... Journal of Crohn's and Colitis 14 (11), 1503-1511, 2020 | 123 | 2020 |
| The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis A Walsh, JL Dixon, GA Ramm, DG Hewett, DJ Lincoln, GJ Anderson, ... Clinical Gastroenterology and Hepatology 4 (11), 1403-1410, 2006 | 123 | 2006 |
| Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity A Walsh, R Palmer, S Travis Gastrointestinal Endoscopy Clinics 24 (3), 367-378, 2014 | 119 | 2014 |
| Outcomes of salvage therapy for steroid‐refractory acute severe ulcerative colitis: ciclosporin vs. infliximab A Croft, A Walsh, J Doecke, R Cooley, M Howlett, G Radford‐Smith Alimentary pharmacology & therapeutics 38 (3), 294-302, 2013 | 98 | 2013 |
| Real-world effectiveness of tofacitinib for moderate to severe ulcerative colitis: a multicentre UK experience S Honap, D Chee, TP Chapman, M Patel, AJ Kent, S Ray, E Sharma, ... Journal of Crohn's and Colitis 14 (10), 1385-1393, 2020 | 80 | 2020 |
| acute severe ulcerative colitis–evidence‐based consensus statements JH Chen, JM Andrews, V Kariyawasam, N Moran, P Gounder, G Collins, ... Alimentary pharmacology & therapeutics 44 (2), 127-144, 2016 | 72 | 2016 |
| Defining faecal calprotectin thresholds as a surrogate for endoscopic and histological disease activity in ulcerative colitis—a prospective analysis A Walsh, A Kormilitzin, C Hinds, V Sexton, O Brain, S Keshav, H Uhlig, ... Journal of Crohn's and Colitis 13 (4), 424-430, 2019 | 61 | 2019 |
